Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 39701 - 39725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Mestranol	Approved Withdrawn	TFPI	7035	downregulated	Mestranol results in decreased expression of TFPI mRNA	2q32.1	A21106
Mestranol	Approved Withdrawn	WWC1	23286	upregulated	Mestranol results in increased expression of WWC1 mRNA	5q34	A21106
Etiracetam	Experimental	CYP17A1	1586	downregulated	etiracetam results in decreased expression of CYP17A1 mRNA	10q24.32	A21543
Etiracetam	Experimental	CYP19A1	1588	downregulated	etiracetam results in decreased expression of CYP19A1 mRNA	15q21.2	A21543
Etiracetam	Experimental	HSD3B2	3284	downregulated	etiracetam results in decreased expression of HSD3B2 mRNA	1p12	A21543
Etiracetam	Experimental	STAR	6770	downregulated	etiracetam results in decreased expression of STAR mRNA	8p11.23	A21543
Etodolac	Approved Investigational Vet Approved	BCL2	596	downregulated	Etodolac results in decreased expression of BCL2 mRNA	18q21.33	A22578 A22579
Etodolac	Approved Investigational Vet Approved	HGF	3082	downregulated	Etodolac results in decreased expression of HGF mRNA	7q21.11	A22580
Etodolac	Approved Investigational Vet Approved	PTGS2	5743	upregulated	Etodolac results in increased expression of PTGS2 mRNA	1q31.1	A10813
Etoposide	Approved Investigational	AGRN	375790	upregulated	Etoposide results in increased expression of AGRN mRNA	1p36.33	A20666
Etoposide	Approved Investigational	ANKRD10	55608	downregulated	Etoposide results in decreased expression of ANKRD10 mRNA	13q34	A21863
Etoposide	Approved Investigational	ANXA4	307	upregulated	Etoposide results in increased expression of ANXA4 mRNA	2p13.3	A20666
Etoposide	Approved Investigational	AREG	374	upregulated	Etoposide results in increased expression of AREG mRNA	4q13.3	A22581
Etoposide	Approved Investigational	ARHGDIB	397	upregulated	Etoposide results in increased expression of ARHGDIB mRNA	12p12.3	A21863
Etoposide	Approved Investigational	ATXN1	6310	downregulated	Etoposide results in decreased expression of ATXN1 mRNA	6p22.3	A21499
Etoposide	Approved Investigational	AXL	558	upregulated	Etoposide results in increased expression of AXL mRNA	19q13.2	A21863
Etoposide	Approved Investigational	BAX	581	upregulated	Etoposide results in increased expression of BAX mRNA	19q13.33	A22582 A21863
Etoposide	Approved Investigational	BBC3	27113	upregulated	Etoposide results in increased expression of BBC3 mRNA	19q13.32	A22266
Etoposide	Approved Investigational	BDNF	627	upregulated	Etoposide results in increased expression of BDNF mRNA	11p14.1	A22583
Etoposide	Approved Investigational	BID	637	upregulated	Etoposide results in increased expression of BID mRNA	22q11.21	A21152
Etoposide	Approved Investigational	BIRC2	329	upregulated	Etoposide results in increased expression of BIRC2 mRNA	11q22.2	A22584
Etoposide	Approved Investigational	BIRC3	330	downregulated	Etoposide results in decreased expression of BIRC3 mRNA	11q22.2	A22582
Etoposide	Approved Investigational	BIRC5	332	upregulated	Etoposide results in increased expression of BIRC5 mRNA	17q25.3	A21152
Etoposide	Approved Investigational	BLM	641	downregulated	Etoposide results in decreased expression of BLM mRNA	15q26.1	A21499
Etoposide	Approved Investigational	BRCA1	672	downregulated	Etoposide results in decreased expression of BRCA1 mRNA	17q21.31	A22448

Displaying entries 39701 - 39725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability